FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”
In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI
It’s Official – UCLA Recognize As 19th Comprehensive Center
FDA Committee to Discuss Policy On Combinations
L.A. County Nears Crucial Decision On Construction Funds
Swiss Report On Radiotherapy Mortality Questioned
ACCC To Consider Cancer Act Changes HSA Problems
New Atlas Showing nonwhite Mortality Rates Available
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- Pam Bondi diagnosed with thyroid cancer
- Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









